[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368313-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368313-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-multifaceted-role-of-phosphodiesterase-4-in-tumor-from-tumorigenesis-to-immunotherapy","The multifaceted role of phosphodiesterase 4 in tumor - from tumorigenesis to immunotherapy","","Phosphodiesterase 4 (PDE4) regulates diverse cellular processes by hydrolyzing the second messenger cAMP. Evidence links abnormal PDE4 expression and activity to initiation and progression of multiple cancers, including lung, colorectal, and hematological malignancies, through effects on proliferation, migration, invasion, and apoptosis. PDE4 also shapes the tumor immune microenvironment by promoting immune evasion, reducing T-cell activation, and skewing tumor-associated macrophages toward a pro-tumor phenotype. PDE4 inhibitors are therefore explored as anti-cancer therapeutics, including in combination with immune checkpoint inhibitors to improve efficacy and reduce chemotherapy-related side effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-multifaceted-role-of-phosphodiesterase-4-in-tumor-from-tumorigenesis-to-immunotherapy/368313/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-multifaceted-role-of-phosphodiesterase-4-in-tumor-from-tumorigenesis-to-immunotherapy/368313.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does phosphodiesterase 4 (PDE4) do in cells?","Question",{"text":63,"@type":64},"PDE4 is an enzyme that specifically hydrolyzes cAMP, regulating multiple cellular functions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is PDE4 linked to tumor development and progression?",{"text":68,"@type":64},"Abnormal PDE4 expression or activity is associated with tumor initiation and progression by facilitating proliferation, migration, invasion, and anti-apoptosis.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are PDE4 inhibitors considered in cancer immunotherapy?",{"text":72,"@type":64},"PDE4 inhibitors can suppress tumor cell growth and restore immune surveillance, and they are being investigated—especially in combination with immune checkpoint inhibitors—to improve efficacy and mitigate chemotherapy side effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368313,1790239109,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","TYPE Review  \nPUBLISHED 10 March 2025  \nDOI 10.3389/fimmu.2025.1528932  \nOPEN ACCESS  \nEDITED BY  \nLi Yuan,  \nXinjiang University, China  \nREVIEWED BY  \nAnn Richmond,  \nVanderbilt University, United States Li Xingrui,  \nXinjiang University, China  \n*CORRESPONDENCE  \nPei-Yuan Li  \n [pyli@tjh.tjmu.edu.cn](pyli@tjh.tjmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 15 November 2024  \nACCEPTED 24 February 2025  \nPUBLISHED 10 March 2025  \nCITATION  \nRen H-l, Zhang S-h and Li P-y (2025)  \nThe multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy.  \nFront. Immunol. 16:1528932 .  \ndoi: 10.3389/fimmu.2025.1528932  \nCOPYRIGHT  \n© 2025 Ren, Zhang and Li. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy  \nHuili-li Ren 1†, Shao-hui Zhang 1† and Pei-yuan Li 2,3*  \n1 Department of Pharmacy, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2 Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 3 Department of Gastroenterology, Wenchang People ’s Hospital, Wenchang, Hainan, China  \nPhosphodiesterase 4 (PDE4) is an enzyme that speciﬁcally hydrolyzes the second messenger cAMP and has a critical role in the regulation of a variety of cellular functions. In recent years, PDE4 has attracted great interest in cancer research, and its role in tumorigenesis and development has been gradually elucidated. Research indicates that abnormal expression or heightened activity of PDE4 is associated with the initiation and progression of multiple cancers, including lung, colorectal, and hematological cancers, by facilitating cell proliferation, migration, invasion, and anti-apoptosis. Moreover, PDE4 also inﬂuences the tumor immune microenvironment, signiﬁcantly immune evasion by suppressing anti-tumor immune responses, reducing T-cell activation, and promoting the polarization of tumor-associated macrophages toward a pro-tumorigenic phenotype. However, the PDE4 family may have both oncogenic and tumor-suppressive effects, which could depend on the speciﬁc type and grade of the tumor. PDE4 inhibitors have garnered substantial interest as potential anti-cancer therapeutics, directly inhibiting tumor cell growth and restoring immune surveillance capabilities to enhance the clearance of tumor cells. Several PDE4 inhibitors are currently under investigation with the aim of exploring their potential in cancer therapy, particularly in combination strategies with immune checkpoint inhibitors, to improve therapeutic efﬁcacy and mitigate the side effects of conventional chemotherapy. This review provides an overview of PDE4 in tumorigenesis, drug resistance, immunotherapy, and the anti-tumor actions of its inhibitors, intending to guide the exploration of PDE4 as a new target in tumor therapy.  \nKEYWORDS  \nphosphodiesterase 4 (PDE4), tumorigenesis, drug resistance, tumor immunity, PDE4 inhibitors  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nPhosphodiesterases (PDEs) are a class of enzymes that catalyze the cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) (1) . The PDE superfamily is divided into 11 families (PDE1-PDE11), classiﬁed by structure and enzymatic properties (2). Serving as a secondary messenger, cAMP plays a crucial role in regulating cell proliferation (3–5), differentiation ","cbCaipSxkLPcyBs0","https://ap.wps.com/l/cbCaipSxkLPcyBs0","pdf",1722455,16,"English","# 1 Introduction\n## Phosphodiesterases (PDEs) and the PDE superfamily\n## PDE4 subtypes and their physiological/pathological roles\n## PDE4 relationships with cancer hallmarks","[{\"question\":\"What does phosphodiesterase 4 (PDE4) do in cells?\",\"answer\":\"PDE4 is an enzyme that specifically hydrolyzes cAMP, regulating multiple cellular functions.\"},{\"question\":\"How is PDE4 linked to tumor development and progression?\",\"answer\":\"Abnormal PDE4 expression or activity is associated with tumor initiation and progression by facilitating proliferation, migration, invasion, and anti-apoptosis.\"},{\"question\":\"Why are PDE4 inhibitors considered in cancer immunotherapy?\",\"answer\":\"PDE4 inhibitors can suppress tumor cell growth and restore immune surveillance, and they are being investigated—especially in combination with immune checkpoint inhibitors—to improve efficacy and mitigate chemotherapy side effects.\"}]","The multifaceted role of phosphodiesterase 4 in tumor - from tumorigenesis to immunotherapy | PDF",1790176234,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdbe7efc7fbf83ebb66c50dff69fca08.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db9563bf861cdee7fcb933e864f3708f.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/861ab9c347194da0c88a27ae7ff52e73.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9eb00cb5b8bdea0390bcbe0ca438dc99.webp",980,1385]